Report: Pharmaceutical Industry Funding Influences Lawmakers in Contentious Medicare Part B Reform Battle

U.S. Representatives Who Sided with Big Pharma Received 82 Percent More Contributions From Industry for 2016 Election Campaigns

WASHINGTON, D.C. –(ENEWSPF)–July 11, 2016.   Members of the U.S. House of Representatives who sided with the pharmaceutical industry in an ongoing lobbying fight over Medicare reforms received 82 percent more in campaign contributions for the 2016 election cycle than members who did not side with the industry, according to a new Public Citizen report.

The